TaiwanJ Pharmaceuticals Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Apr '26 Apr 1, 2026	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Market Capitalization	603	657	1,108	796	759	1,003
Market Cap Growth	-17.90%	-40.71%	39.15%	4.93%	-24.34%	24.63%
Enterprise Value	531	609	1,035	726	662	970
Last Close Price	7.52	8.20	14.68	10.55	10.05	13.29
PS Ratio	-	-	48.72	51.86	34.41	-
PB Ratio	7.30	6.91	16.55	11.12	4.64	5.70
P/TBV Ratio	7.30	6.91	16.64	11.27	8.75	10.18
EV/Sales Ratio	-	-	45.50	47.31	30.01	-
Debt / Equity Ratio	0.03	0.01	0.02	0.03	0.00	0.01
Net Debt / Equity Ratio	-0.86	-0.92	-0.86	-0.82	-0.50	-0.53
Net Debt / EBITDA Ratio	2.95	3.38	10.89	2.87	9.05	2.33
Net Debt / FCF Ratio	3.18	3.85	25.49	2.64	8.22	2.24
Asset Turnover	-	-	0.30	0.12	0.13	-
Quick Ratio	18.76	16.21	10.36	10.12	12.87	14.35
Current Ratio	18.85	16.31	10.43	10.15	12.90	14.41
Return on Equity (ROE)	-36.25%	-27.58%	-8.73%	-78.67%	-7.32%	-25.92%
Return on Assets (ROA)	-20.86%	-19.33%	-5.39%	-48.17%	-3.44%	-14.71%
Return on Invested Capital (ROIC)	-222.20%	-313.44%	-59.94%	-205.73%	-11.84%	-45.36%
Return on Capital Employed (ROCE)	-29.90%	-28.40%	-9.80%	-132.50%	-5.90%	-22.90%
Earnings Yield	-4.21%	-3.40%	-0.55%	-11.61%	-1.64%	-4.23%
FCF Yield	-3.72%	-3.44%	-0.20%	-2.80%	-1.32%	-4.12%
Buyback Yield / Dilution	-5.22%	-1.89%	-	-0.03%	-6.07%	-2.98%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.